Injury Rehab: Best Peptides Ranked by Research

Peptides studied for tendon, ligament, muscle, and bone healing in injury recovery contexts.

Written by WhatPeptide Editorial Team · Last updated 2026-03-18

Ranked by published research relevance. Ranking order is editorially independent of affiliate relationships.

Not sure where to start? Take our free quiz

How we rank

We score each peptide's relevance to injury rehab on a 0–100 scale based on the breadth, quality, and consistency of published research. Higher scores reflect stronger and more direct research support — not commercial relationships. Our rankings are not medical recommendations.

#1

BPC-157

Animal studies only FDA Category 2 Healing & Recovery
Injury Rehab
Moderate relevance 65

BPC-157 appears to modulate nitric oxide signaling and growth-factor pathways including VEGF and EGF. Preclinical work suggests effects on angiogenesis, tendon-to-bone healing, and epithelial repair. Evidence is based primarily on animal and in-vitro studies.

Subcutaneous Half-life: Estimated <30 min systemic; stable >24h in gastric juice Range: 200-500 mcg daily (research/compounding context)
Injection-site irritation Nausea Headache
#2

TB-500

Animal studies only FDA Category 2 Healing & Recovery
Injury Rehab
Moderate relevance 60

TB-500 is linked to actin-binding and cellular migration pathways associated with tissue remodeling. Thymosin beta-4 biology also intersects with angiogenesis and anti-inflammatory signaling in animal data. Evidence is based primarily on animal and in-vitro studies.

Subcutaneous Half-life: Estimated 2-6 hours (active fragment uncertain) Range: 2-5 mg weekly divided doses (research context)
Injection-site discomfort Fatigue Headache
#3

CJC-1295

Moderate evidence FDA Category 2 GH Secretagogue
Injury Rehab
Some relevance 35

CJC-1295 acts at GHRH receptors in the pituitary to increase pulsatile GH release and downstream IGF-1 signaling. DAC conjugation extends circulation time compared with shorter GHRH analogs. Evidence is supported by moderate clinical and preclinical evidence.

Subcutaneous Half-life: About 5-8 days (DAC form) Range: 1-2 mg weekly (DAC versions in compounding context)
Water retention Tingling Injection-site irritation

All peptides for injury rehab compared

How peptides relate to injury rehabilitation research

Injury rehabilitation is one of the most active areas of peptide research, driven by the limitations of conventional approaches to tendon, ligament, and cartilage repair. BPC-157 has been studied in over 100 preclinical models relevant to musculoskeletal injury, including Achilles tendon transection, MCL tears, muscle crushing injuries, and bone fractures. Its effects appear to involve accelerated collagen deposition, angiogenesis at the injury site, and modulation of growth factor expression.

TB-500 (thymosin beta-4 fragment) complements BPC-157 through different mechanisms — primarily cellular migration and actin regulation. In animal models, TB-500 has shown effects on wound healing, cardiac tissue repair after infarction, and reduction of scar tissue formation. The combination of BPC-157 and TB-500 is one of the most commonly discussed peptide stacks in the rehabilitation context.

While preclinical results for injury rehabilitation peptides are robust and consistent, the translation to controlled human clinical trials remains limited. Most human evidence comes from case reports, observational studies, and clinical experience rather than randomized controlled trials. This gap between preclinical promise and clinical validation is a critical consideration when evaluating these peptides.

Key mechanisms

Collagen deposition acceleration

BPC-157 enhances type I collagen production and organization at tendon and ligament injury sites, potentially accelerating the timeline from inflammatory to proliferative healing phases.

Cellular migration and remodeling

TB-500 promotes the migration of reparative cells to injury sites and modulates actin polymerization, supporting tissue remodeling and reducing disorganized scar formation.

Anti-fibrotic effects

Both BPC-157 and TB-500 have shown anti-fibrotic properties in animal models, potentially reducing excessive scar tissue that can impair function and strength at healed injury sites.

Common peptide stacks for injury rehab

Stacking research is limited. Consult a healthcare provider before combining peptides.

BPC-157

Healing & Recovery · Score: 65

TB-500

Healing & Recovery · Score: 60

BPC-157 and TB-500 are commonly discussed together for injury rehab-related goals. Both rank in the top tier for this category.

BPC-157

Healing & Recovery · Score: 65

GHK-Cu

Cosmetic · Score: 35

BPC-157 and GHK-Cu are commonly discussed together for injury rehab-related goals. Both rank in the top tier for this category.

Safety considerations for injury rehab peptides

Purity testing is especially critical for injectable rehabilitation peptides. BPC-157 and TB-500 from unverified sources may contain contaminants, degradation products, or incorrect concentrations.
Peptides should complement — not replace — standard rehabilitation protocols. Physical therapy, progressive loading, and proper rest remain the foundation of injury recovery.
Report any injection site reactions (persistent redness, swelling, warmth) immediately. These may indicate contamination, infection, or allergic reaction requiring medical attention.

Not sure which peptide is right for you?

Our recommendation quiz considers your goals, experience level, and health profile to find your best matches.

Take the free quiz

Frequently asked questions about peptides for injury rehab

What is the best peptide for injury rehab? +
Based on published research relevance, BPC-157 ranks highest for injury rehab with a score of 65/100. Its evidence is based primarily on animal and in-vitro studies.
Are peptides for injury rehab safe? +
Safety depends on the specific peptide, your health profile, and proper sourcing. All peptides carry potential side effects. We recommend consulting a healthcare provider, purchasing from reputable sources, and using third-party purity testing before use. Our safety section above covers goal-specific considerations.
Do I need a prescription for injury rehab peptides? +
It varies by peptide and jurisdiction. Most peptides in this category are not FDA-approved. Compounding pharmacies may provide some peptides with a physician's order. Regulatory status varies by country.
How long do injury rehab peptides take to work? +
Timelines vary significantly by peptide and individual. GLP-1 agonists may show effects within weeks, while GH secretagogues typically require 4-8 weeks for noticeable changes. Recovery peptides like BPC-157 are often studied over 2-4 week protocols in animal models. Individual responses, dosing, and administration consistency all affect timelines.
Can I stack peptides for injury rehab? +
Some peptides are commonly used in combination, but research on specific combinations is limited. BPC-157 and TB-500 are frequently discussed together for this goal. Always consult a healthcare provider before combining peptides.
Where can I buy peptides for injury rehab? +
Peptides may be obtained through compounding pharmacies (with a physician's order), licensed research suppliers, or online vendors. Regardless of source, we strongly recommend third-party purity and identity testing before use. See our testing guide for protocols. Some links on this page are affiliate links — see our disclosure for details.

Explore other goals